HomeAlfuzosin

Alfuzosin

Check Alfuzosin Interactions →
20 interactions on record

Alfuzosin has 20 known drug interactions based on U.S. FDA drug labeling data. Of these, 16 are contraindicated combinations that should be avoided entirely. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Alfuzosin Hydrochloride, Atazanavir, Atazanavir And Cobicistat. Patients taking Alfuzosin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
20
Contraindicated
16
Major
3
Moderate
1

Contraindicated (16)

Major (3)

  • Alfuzosin + ItraconazoleItraconazole increases alfuzosin concentrations, increasing risk of adverse reactions. Not recommended during and 2 week
  • Alfuzosin + TadalafilClinical pharmacology studies conducted with coadministration of tadalafil with alfuzosin. Additive blood-pressure-lower
  • Alfuzosin + VardenafilAlpha-blocker interaction with additive blood pressure lowering effects. Clinical pharmacology studies conducted; cautio

Moderate (1)

Alfuzosin + Alfuzosin HydrochlorideContraindicated

7 DRUG INTERACTIONS Concomitant use of PDE5 inhibitors with alpha adrenergic antagonists, including alfuzosin hydrochloride extended-release tablets, can potentially cause symptomatic hypotension (5.4 , 7.4) 7.1 CYP3A4 Inhibitors Alfuzosin hydrochloride extended-release tablets are contraindicated for use with potent CYP3A4 inhibitors such as ketoconazole, itraconazole, or ritonavir, since alfuzosin blood levels are increased [see Contraindications (4) , Warnings and Precautions (5.4) and Clinical Pharmacology (12.3) ] . 7.2 Alpha Adrenergic Antagonists The pharmacokinetic and pharmacodynamic interactions between alfuzosin hydrochloride extended-release tablets and other alpha adrenergic antagonists have not been determined. However, interactions may be expected, and alfuzosin hydrochloride extended-release tablets should not be used in combination with other alpha adrenergic antagonists [see Warnings and Precautions (5.4) ] .

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.